About Careers MedBlog Contact us

Anti-Retrovirals in Africa, not a distant dream

by Medindia Content Team on February 9, 2006 at 3:08 PM
Font : A-A+

Anti-Retrovirals in Africa, not a distant dream

Ranbaxy Laboratories (India) has entered into a joint venture with a South African company that will support Ranbaxy's key agenda of enabling antiretroviral drugs in Africa. A joint venture between Ranbaxy and South Africa based Community Investment Holdings has been signed, that will give authority for this company to sell the drugs in Africa. The CEO of Ranbaxy South Africa, Desmond Brothers, conveyed that this venture will permit the company to make the drugs available at a low cost.

Ranbaxy will retain 70% of the venture, called Sonke Pharmaceuticals, in charge of marketing the products under the brand name 'Sonke'. Governments, retail pharmacists, HIV/AIDS disease management companies, nongovernmental organizations and independent community treatment organizations in South Africa, Botswana and Namibia, will be the contact points for sales of the antiretroviral drugs.



Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Anti-Retrovirals in Africa, not a distant dream Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests